R Küppers, ULF Klein, ML Hansmann… - New England Journal …, 1999 - Mass Medical Soc
The origin of human lymphomas has been studied by various approaches, including histology and immunophenotyping. In some types of lymphoma these studies suggested the …
A Cossarizza, HD Chang, A Radbruch… - European journal of …, 2019 - Wiley Online Library
These guidelines are a consensus work of a considerable number of members of the immunology and flow cytometry community. They provide the theory and key practical …
W Matsui, Q Wang, JP Barber, S Brennan, BD Smith… - Cancer research, 2008 - AACR
Many agents are active in multiple myeloma, but the majority of patients relapse. This clinical pattern suggests most cancer cells are eliminated, but cells with the clonogenic potential to …
MULTIPLE MYELOMA (MM) is a clonal B-cell neo-plasm that affects terminally differentiated B cells (ie, plasma cells) and may proceed through different phases: an inactive phase in …
Multiple myeloma (MM), a malignant tumor of somatically mutated, isotype-switched plasma cells (PC), usually arises from a common benign PC tumor called Monoclonal Gammopathy …
Antigen-driven selection has been implicated in the pathogenesis of monoclonal gammopathies. Patients with Gaucher's disease have an increased risk of monoclonal …
Multiple myeloma (MM) is a neoplasm of post–germinal center, terminally differentiated B cells. It is characterized by a multifocal proliferation of clonal, long-lived plasma cells within …
This study analyzed the frequency and clinical significance of t (4; 14)(p16; q32) in multiple myeloma (MM) among 208 patients with MM and 52 patients with monoclonal gammopathy …
B Klein, XG Zhang, ZY Lu, R Bataille - Blood, 1995 - Elsevier
WITHIN THE LAST 5 YEARS, two major findings have advanced our knowledge of the biology of human multiple myeloma (MM). First, somatic mutations without intraclonal …